Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E SHEPPARD

Showing results (221-230 of 276) with videos related to

Pageof 28
Sort By:
Pediatric Blood & Cancer|May 17, 2023
Pathogenic variants in PIK3CA are associated with clinical phenotypes of kaposiform lymphangiomatosis, generalized lymphatic anomaly, and central conducting lymphatic anomalyJeremy M Grenier, Alexandra J Borst, Sarah E Sheppard, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 1, 2019
Androgenetic chimerism as an etiology for Beckwith-Wiedemann syndrome: diagnosis and managementSarah E Sheppard, Emilie Lalonde, N Scott Adzick, et al.
Plos Biology|June 5, 2015
Host-Pathogen Coevolution: The Selective Advantage of Bacillus thuringiensis Virulence and Its Cry Toxin GenesLeila Masri, Antoine Branca, Anna E Sheppard, et al.
Scientific Reports|February 6, 2019
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapyEmily J Lelliott, Carleen Cullinane, Claire A Martin, et al.
International Journal of Cancer|December 16, 2017
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistanceClaire A Martin, Carleen Cullinane, Laura Kirby, et al.
Cancer Discovery|May 17, 2019
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation StudyAmit Khot, Natalie Brajanovski, Donald P Cameron, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Nested Russian Doll-Like Genetic Mobility Drives Rapid Dissemination of the Carbapenem Resistance Gene blaKPCAnna E Sheppard, Nicole Stoesser, Daniel J Wilson, et al.
Cancer Immunology Research|December 11, 2020
Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in MelanomaEmily J Lelliott, Stefano Mangiola, Kelly M Ramsbottom, et al.
American Journal of Human Genetics|April 11, 2020
Bi-allelic Loss-of-Function Variants in NUP188 Cause a Recognizable Syndrome Characterized by Neurologic, Ocular, and Cardiac AbnormalitiesAlison M Muir, Jennifer L Cohen, Sarah E Sheppard, et al.
Science Signaling|August 20, 2015
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanomaRachel Ramsdale, Robert N Jorissen, Frederic Z Li, et al.
Pageof 28

Showing results (221-230 of 276) with videos related to

Sort By:
Pageof 28
Pediatric Blood & Cancer|May 17, 2023
Pathogenic variants in PIK3CA are associated with clinical phenotypes of kaposiform lymphangiomatosis, generalized lymphatic anomaly, and central conducting lymphatic anomalyJeremy M Grenier, Alexandra J Borst, Sarah E Sheppard, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 1, 2019
Androgenetic chimerism as an etiology for Beckwith-Wiedemann syndrome: diagnosis and managementSarah E Sheppard, Emilie Lalonde, N Scott Adzick, et al.
Plos Biology|June 5, 2015
Host-Pathogen Coevolution: The Selective Advantage of Bacillus thuringiensis Virulence and Its Cry Toxin GenesLeila Masri, Antoine Branca, Anna E Sheppard, et al.
Scientific Reports|February 6, 2019
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapyEmily J Lelliott, Carleen Cullinane, Claire A Martin, et al.
International Journal of Cancer|December 16, 2017
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistanceClaire A Martin, Carleen Cullinane, Laura Kirby, et al.
Cancer Discovery|May 17, 2019
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation StudyAmit Khot, Natalie Brajanovski, Donald P Cameron, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Nested Russian Doll-Like Genetic Mobility Drives Rapid Dissemination of the Carbapenem Resistance Gene blaKPCAnna E Sheppard, Nicole Stoesser, Daniel J Wilson, et al.
Cancer Immunology Research|December 11, 2020
Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in MelanomaEmily J Lelliott, Stefano Mangiola, Kelly M Ramsbottom, et al.
American Journal of Human Genetics|April 11, 2020
Bi-allelic Loss-of-Function Variants in NUP188 Cause a Recognizable Syndrome Characterized by Neurologic, Ocular, and Cardiac AbnormalitiesAlison M Muir, Jennifer L Cohen, Sarah E Sheppard, et al.
Science Signaling|August 20, 2015
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanomaRachel Ramsdale, Robert N Jorissen, Frederic Z Li, et al.
Pageof 28